DNA restriction fragment length polymorphism differentiates recurrence from relapse in treatment failures of Streptococcus pyogenes pharyngitis

J Med Microbiol. 1992 Sep;37(3):162-4. doi: 10.1099/00222615-37-3-162.

Abstract

In the evaluation of treatment failure in Streptococcus pyogenes pharyngitis it is necessary to distinguish between persistence of the original streptococcus and acquisition of a new strain. We used the analysis of restriction fragment length polymorphism (RFLP) of total DNA and of ribosomal DNA (rDNA) regions (ribotypes) as epidemiological tools to compare 43 pre- and post-treatment S. pyogenes strains obtained from 20 patients. In 16 cases pre- and post-treatment strains gave indistinguishable RFLP patterns of total DNA, strongly suggesting relapse with the same strain. However, in four cases different patterns were obtained for the pre- and post-treatment isolates, indicating recurrence due to the acquisition of a new strain. Ribotyping did not improve discrimination among strains. Thus, analysis of DNA RFLP is a promising method for distinguishing recurrence from relapse in failures of pharyngitis treatment.

Publication types

  • Comparative Study

MeSH terms

  • DNA, Bacterial / analysis*
  • DNA, Ribosomal / analysis
  • Deoxyribonuclease HindIII
  • Deoxyribonucleases, Type II Site-Specific
  • Double-Blind Method
  • Follow-Up Studies
  • Humans
  • Pharyngitis / drug therapy
  • Pharyngitis / microbiology*
  • Polymorphism, Restriction Fragment Length*
  • Recurrence
  • Restriction Mapping
  • Streptococcal Infections / drug therapy
  • Streptococcal Infections / microbiology*
  • Streptococcus pyogenes / classification*
  • Streptococcus pyogenes / genetics

Substances

  • DNA, Bacterial
  • DNA, Ribosomal
  • Deoxyribonuclease HindIII
  • CAGCTG-specific type II deoxyribonucleases
  • Deoxyribonucleases, Type II Site-Specific